V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195697 | 20088306 | 0 | 0 | Palliative (P) | 2019-01-28 | 2019-01-28 | CAP + RT | 02 | N | OXALIPLATIN | 101214339 |
| 20195709 | 20088307 | 0 | 30.4 | 03 | 2017-01-25 | 2017-02-08 | Gemcitabine + Paclitaxel | 01 | N | ARISTOTLE TRIAL | 101216237 |
| 20195869 | 20088308 | 1.7 | 57 | 03 | 2018-09-14 | 2018-09-14 | Paclitaxel 7 day | 02 | N | FOXTROT TRIAL | 101560864 |
| 20196015 | 20088310 | 1.66 | 58 | Palliative (P) | 2020-02-12 | 2020-02-15 | CAP + RT | 02 | N | AZACITIDINE | 100701572 |
| 20196042 | 20088311 | 0 | 0 | 03 | 2019-05-28 | 2019-05-31 | Doxorubin 50mg/m2 | N | N | NOT MATCHED | 100362173 |
| 20196130 | 20088312 | 1.67 | 82.6 | Palliative (P) | 2019-09-05 | 2019-09-05 | Paclitaxel 7 day | null | N | CARBOPLATIN + PEMETREXED | 100550422 |
| 20196716 | 20088315 | 1.74 | 80.5 | null | 2017-02-25 | 2017-03-04 | Carboplatin + Vinorelbine IV | N | N | DABRAFENIB + TRAMETINIB | 100012484 |
| 20196912 | 20088316 | 1.71 | 77.45 | 03 | 2018-08-12 | 2018-08-15 | FLUOROURACIL + RT | 2 | N | ABIRATERONE | 101444505 |
| 20196937 | 20088317 | 1.83 | 94.2 | null | 2017-11-12 | 2017-11-15 | Sunitinib | Y | N | AML19 TRIAL | 100340378 |
| 20196974 | 20088318 | 1.76 | 66.8 | Palliative (P) | 2018-03-26 | 2018-03-28 | PEMBROLIZUMAB | 02 | N | CAP + RT | 101660556 |
| 20197259 | 20088320 | 1.62 | 78 | null | 2018-08-24 | 2018-08-25 | FOXTROT TRIAL | 02 | N | ACELARATE TRIAL | 100471982 |
| 20197279 | 20088321 | 1.76 | 78 | null | 2019-04-15 | 2019-04-19 | CHOP R - 21 days | 02 | N | CAPITAL TRIAL | 101578610 |
| 20197298 | 20088322 | null | null | 03 | 2017-07-04 | 2017-07-04 | Sunitinib | 02 | Y | ARISTOTLE TRIAL | 101227674 |
| 20197388 | 20088323 | 1.55 | 117.4 | Neo-adjuvant (N) | 2019-04-12 | 2019-04-12 | BORTEZOMIB + THALIDOMIDE | 02 | N | OXALIPLATIN | 101786282 |
| 20197524 | 20088325 | 1.65 | 93 | Palliative (P) | 2018-09-12 | 2018-10-01 | CHOP R - 21 days | 02 | N | TRASTUZUMAB EMTANSINE | 100178257 |
| 20197527 | 20088326 | 1.57 | 72.8 | null | 2019-12-29 | 2020-01-02 | Capecitabine + Streptozocin | 02 | N | FEC | 100350917 |
| 20197647 | 20088327 | 1.7 | 89 | 03 | 2019-07-08 | 2019-08-09 | GO2 TRIAL | 02 | N | EVEROLIMUS | 100225034 |
| 20197652 | 20088328 | 1.7 | 82 | Palliative (P) | 2017-11-29 | 2017-12-12 | CARBOPLATIN + FLUOROURACIL | 01 | N | FLUOROURACIL + RT | 101151692 |
| 20197694 | 20088330 | 1.77 | 51.5 | 03 | 2018-09-23 | 2018-09-24 | Docetaxel | 02 | Y | NEO-AEGIS TRIAL | 100150951 |
| 20197771 | 20088331 | 1.65 | null | 03 | 2019-03-06 | 2019-03-06 | Bevacizumab + Cape + Oxali 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101740973 |
| 20198018 | 20088334 | 1.62 | 70.8 | Palliative (P) | 2021-10-10 | 2021-10-10 | Irinotecan | 02 | N | CAPECITABINE + CARBOPLATIN + RT | 100764418 |
| 20198192 | 20088337 | 1.48 | 59.8 | 03 | null | 2019-05-18 | PEMBROLIZUMAB | N | N | EOF | 100980667 |
| 20198241 | 20088338 | null | null | null | 2018-02-18 | 2018-03-07 | null | 02 | N | BCG | 101179184 |
| 20198359 | 20088340 | 1.67 | 74.2 | 03 | null | 2017-05-23 | ESPAC-4 TRIAL | 99 | N | RALTITREXED | 100993571 |
| 20198415 | 20088341 | 1.78 | 67.9 | Palliative (P) | 2019-04-06 | 2019-04-10 | ARISTOTLE TRIAL | 02 | N | FLUOROURACIL + STREPTOZOCIN | 101749489 |
| 20198502 | 20088342 | 1.69 | 85.8 | Palliative (P) | 2016-09-20 | 2016-09-22 | CISPLATIN + FLUOROURACIL + RT | null | N | MITOMYCIN | 100826449 |
| 20198673 | 20088343 | 1.67 | 87.8 | Palliative (P) | null | 2018-05-16 | Venetoclax | 02 | N | ACTICCA-1 TRIAL | 101189947 |
| 20198855 | 20088345 | 1.7 | null | Neo-adjuvant (N) | null | 2019-12-21 | CARBOPLATIN + FLUOROURACIL | 02 | null | RITUXIMAB | 100140075 |
| 20198897 | 20088346 | 1.7 | 70.8 | Palliative (P) | 2018-09-17 | 2018-09-17 | Hydroxycarbamide | N | N | GEMCARBO | 100510444 |
| 20198916 | 20088347 | 1.75 | 78.9 | null | 2019-03-15 | 2019-03-28 | ECarboX | N | Y | CARBOPLATIN + RT | 100498854 |
| 20199016 | 20088348 | 0 | 0 | 03 | 2017-02-23 | 2017-03-06 | ECarboX | N | N | PHITT C CDDP-M | 100701150 |
| 20199042 | 20088349 | 1.68 | 56 | null | 2019-09-29 | 2019-09-29 | HEP SIOPEL 6 | null | null | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100277634 |
| 20199059 | 20088350 | 1.78 | 91.2 | Neo-adjuvant (N) | 2019-11-26 | 2019-12-18 | RUXOLITINIB | 02 | N | CISPLATIN + FLUOROURACIL + MITOMYCIN | 101478725 |
| 20199644 | 20088354 | 1.64 | 107 | Palliative (P) | 2012-10-13 | 2019-03-17 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100519882 |
| 20199648 | 20088355 | 1.68 | 67.8 | Palliative (P) | 2016-07-01 | 2016-07-02 | Hydroxycarbamide | 02 | Y | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100122884 |
| 20199729 | 20088356 | 1.82 | 59.6 | Palliative (P) | 2019-11-30 | 2019-12-17 | PRIMUS 002 TRIAL | 02 | N | CAP + RT | 100995507 |
| 20199756 | 20088357 | 1.71 | 92.3 | 03 | 2017-12-14 | 2018-01-17 | Bortezomib + MELPHALAN | 02 | N | HYDROXYCARBAMIDE | 100138466 |
| 20199788 | 20088358 | 0 | 0 | Palliative (P) | 2016-12-09 | 2016-12-17 | VEDex | 02 | null | SCOPE2 TRIAL | 100208745 |
| 20199813 | 20088359 | 1.66 | 0 | 03 | 2016-09-02 | 2016-09-21 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | 02 | N | SCOPE2 TRIAL | 100408320 |
| 20200094 | 20088360 | 1.78 | 83.6 | 03 | 2018-06-03 | 2018-06-13 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101148667 |
| 20200205 | 20088361 | 1.74 | 82.5 | 03 | 2016-11-09 | 2016-12-12 | SCOPE 2 TRIAL | 01 | Y | OXALIPLATIN | 100355560 |
| 20200245 | 20088362 | 1.84 | 82.7 | 03 | null | 2018-01-27 | NB HRNBL-1 BUMEL MAT | 02 | N | GEMCARBO | 100320081 |
| 20200367 | 20088363 | null | 11.2 | 03 | 2016-07-05 | 2016-07-05 | MIC | N | N | DOCETAXEL | 101569823 |
| 20200379 | 20088364 | 1.82 | 77.5 | null | 2019-06-01 | 2019-06-14 | PLATO Trials | 02 | N | PLATO TRIAL | 101544874 |
| 20200450 | 20088365 | 1.62 | 52.7 | Palliative (P) | 2019-02-04 | 2019-02-05 | OXALIPLATIN | 02 | N | PACLITAXEL | 101451940 |
| 20200558 | 20088366 | 1.62 | 95 | Neo-adjuvant (N) | 2019-11-26 | 2019-11-26 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 01 | N | GEMCARBO | 101446932 |
| 20200696 | 20088367 | 1.79 | null | 03 | null | 2020-01-04 | DABRAFENIB + TRAMETINIB | 02 | N | CAP + RT | 100734913 |
| 20200777 | 20088368 | 1.87 | 82.6 | Palliative (P) | 2018-07-25 | 2018-08-02 | LENALIDOMIDE | 02 | N | PANITUMUMAB | 100973365 |
| 20200806 | 20088369 | 1.77 | 63 | Palliative (P) | 2019-04-12 | 2019-04-12 | Paclitaxel (2 or 3 weekly) | 01 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101281774 |
| 20200913 | 20088371 | 1.71 | 66.6 | 03 | 2019-12-19 | 2019-12-19 | REGORAFENIB | 02 | N | ACTICCA-1 TRIAL | 100060037 |